UK Mortgage Approvals Rise in February
March 30, 20267m readStandard
Fazen Markets Research
AI-Enhanced Analysis
UK mortgagesBank of Englandhousing marketcredit cycleFazen Capital
Fazen Markets Research
AI-Enhanced Analysis
UK lenders approved more mortgages than market forecasts in February 2026, signalling a resilience in UK household credit demand after a period of volatility. The Bank of England's published series (reported by Investing.com on Mar 30, 2026) showed approvals rose to 56,700 in February, up from 54,200 in January and beating a market consensus of roughly 53,800. On a year‑on‑year basis approvals were approximately 6.4% higher than February 2025's 53,350, underscoring nascent recovery momentum in purchase activity. The data comes against a backdrop of a Bank Rate that has remained elevated (5.25% at the time of the March 2026 MPC decision) and housing market indicators that have oscillated between regional strength and central caution. For institutional investors, the ratio of approvals to completions and the evolving spread between fixed mortgage rates and the Bank Rate are material signals for credit risk and securitisation pipelines.
February's uptick follows six months of noisy readings for mortgage approvals, where month‑to‑month volatility has complicated both macro forecasting and bank balance‑sheet planning. The Bank of England series is a timely lead indicator for net mortgage lending (which lags approvals by one to three months as transactions complete) and is therefore used by lenders and regulators to monitor credit conditions. The recent increase in approvals — to 56,700 in February 2026 (Bank of England / Investing.com, Mar 30, 2026) — should be interpreted in light of stronger employment data (UK unemployment rate of 3.9% in Q4 2025 per ONS) and a modest pick‑up in consumer confidence indices in early 2026.
Historically, approvals have tended to lead house price inflection points by several months. For example, after the 2019‑20 slowdown, approvals troughed and then led a recovery in transactions and prices in 2021. Comparing current approvals to the ten‑year monthly average (approximately 63,000) shows the sector is recovering but not yet at pre‑tightening volumes; approvals remain around 10% below the decade mean. That gap is informative for stress testing mortgage servicers and projecting mortgage‑backed securities (MBS) issuance volumes into H2 2026.
Policy context matters: the Monetary Policy Committee held Bank Rate at 5.25% on Mar 20, 2026, citing sticky services inflation and wage growth (Bank of England, Mar 2026). Elevated policy rates have pushed average two‑ and five‑year fixed mortgage pricing wider than a year ago, but the approval rise indicates buyers are increasingly able or willing to transact at prevailing spreads. Lenders' internal underwriting thresholds, loan‑to‑income caps and risk appetite will govern how persistent the approvals improvement becomes.
The headline number — 56,700 approvals in February — masks heterogeneity across borrower types and geographies. First‑time buyer approvals, which constitute a meaningful share of activity, rose around 3.1% month on month, while remortgage approvals increased by approximately 5.8% (Bank of England breakdown, Mar 30, 2026). By region, approvals recovered faster in the North West and Yorkshire than in London, consistent with a two‑track market where affordability improvements have been more pronounced outside the capital.
Credit‑score mixes and loan‑to‑income (LTI) distributions shifted only modestly: the share of approvals at LTI above 4.5 remained near 12%, broadly stable versus January. Average mortgage sizes rose slightly, reflecting a combination of house price resilience in certain UK regions and continued demand for detached inventory. From a securitisation perspective, the flow of newly approved mortgages at higher average balances could lift the underlying collateral value in new RMBS issuance, while underwriting stability supports investors' assumptions around seasoning and default curves.
Comparisons with other credit indicators are illuminating. Net mortgage lending (BoE monetary aggregates) continues to lag approvals; net lending in January 2026 showed a 0.8% monthly expansion, indicating frictions between approvals and completions (Bank of England, Feb 2026). Meanwhile, fixed‑rate mortgage pricing: the two‑year fixed average for new deals is approximately 4.9% and five‑year fixed around 4.6% (market aggregator series, Mar 2026). That spread relative to Bank Rate implies persistent margin pressure for lenders, which could drive pricing or product mix adjustments through the year.
For large retail banks and building societies, a rise in approvals translates into two immediate balance‑sheet and revenue implications: an expanding origination pipeline and potential for higher net interest income, assuming margins are maintained on new flows. Yet, margins will be squeezed unless deposit funding rebalances or term funding is sourced efficiently; deposit costs have risen roughly 70–120 basis points versus two years ago for many midsize lenders (bank financials, 2025–26). Increased approvals can lift fee income from conveyancing and arrangement fees, but this is a cyclical boost that depends on completions.
For the buy‑to‑let (BTL) segment and specialist lenders, the momentum in approvals suggests opportunity but also caution. BTL approvals rose modestly in February, though regulatory scrutiny of interest coverage ratios and stress testing for higher vacancy rates persists (FCA supervisory statements, 2025). Mortgage insurers and RMBS investors should price in a moderate increase in originations against a backdrop where underwriting standards remain conservative relative to pre‑2008 peaks.
From a capital markets perspective, higher approvals feed the pipeline for new RMBS and covered bond issuance. UK gross mortgage lending tends to lead issuance by one to two quarters; if approvals maintain above‑consensus levels through Q2 2026, collateral supply could relieve some margin compression in secondary markets for existing RMBS. Sovereign and macro stress tests will maintain focus on the interaction between policy rate durability and mortgage performance trajectories.
Key downside risks that could reverse the approvals momentum include a sharper‑than‑expected slowdown in real incomes, a reversal in regional labour market strength, or a renewed spike in long‑term market rates. If gilt yields climb substantially from current levels, fixed mortgage pricing would reprice and affordability pockets could contract rapidly, pressuring approvals. A 100bp shock in medium‑term yields would materially widen mortgage pricing and could reduce approvals by an estimated 10–15% in modelling scenarios used by major UK lenders (internal industry stress tests, 2025).
Credit quality risk is also asymmetric: while current underwriting appears stable, the loaf of approvals concentrated at higher LTI bands could become a vulnerability if unemployment or income growth reverses. Loan seasoning and early‑payment performance over the next 12 months will be critical in determining vintage quality; investors should monitor early arrears (first two months) and forbearance requests as leading indicators.
Regulatory and policy uncertainty presents a second order risk. Any changes to stamp duty, help‑to‑buy‑style programmes, or prudential adjustments to mortgage capital treatment could materially influence approval volumes. Market participants should model counterfactuals where policy eases house purchase support (reducing approvals by an estimated 5–8%) or where fiscal incentives are amplified (raising approvals by a comparable magnitude).
Fazen Capital sees February's approvals increase as a sign that the UK mortgage market is adjusting to a higher‑rate environment rather than collapsing under it. Contrarian to narratives that equate high policy rates with permanently depressed mortgage demand, our analysis suggests a re‑allocation: borrowers are trading down term certainty for affordability — shorter fixed terms and higher initial loan balances — while lenders preserve underwriting discipline. This dynamic implies that while headline approvals can rise, the credit sensitivity of portfolios may increase because borrowers are taking on more exposure to future rate resets.
We also highlight the structural divergence between regions: our proprietary regional demand index shows that the North and Midlands contribute disproportionately to the approvals growth, whereas London‑centric lenders may still experience muted flows. For investors in RMBS and bank equity, this suggests selective exposure to originators with diversified regional footprints and robust funding franchises.
Fazen Capital recommends monitoring flow indicators (approvals, new lending volumes, early arrears) and term‑structure dynamics (gilt yields, swap spreads) rather than relying solely on headline approvals. Our conviction is that a sustained rally in approvals would be credible only if accompanied by stabilising or improving early‑payment metrics and a flattening of the long‑end yield curve.
Going into Q2 2026, the market will watch whether approvals translate into completions and whether the nascent demand can be sustained as lenders cycle through balance‑sheet re‑pricing and funding adjustments. If approvals remain above 55,000 monthly, it would support a scenario of gradual normalisation in gross lending volumes and increased RMBS supply in H2 2026. Conversely, renewed volatility in long yields or a deterioration in labour market indicators would likely compress approvals quickly, foreshortening the recovery.
Investors should also track policy signals from the BoE, where inflation and wage growth data will govern the persistence of the Bank Rate. Our baseline scenario assumes a stable Bank Rate through mid‑2026 with marginal adjustments only if inflation prints deviate materially from expectations. Under that baseline, approvals growth should translate into modest but meaningful support for mortgage originations and securitisation pipelines across the UK.
Q: What are the practical implications for RMBS investors from a rise in approvals?
A: Higher approvals tend to expand collateral pipelines, which can ease scarcity premia in the secondary RMBS market and broaden issuance. However, investors should demand transparency on underwriting changes and early‑payment performance; a 3–6 month window is often sufficient to observe whether approval flows are translating into healthy completions and seasoning.
Q: How have approvals performed historically during prior bank‑rate hiking cycles?
A: In previous cycles (e.g., 2006–2007), approvals led price and volume inflection points but with higher default risks later as resets occurred. By contrast, the post‑2020 cycle shows more conservative underwriting and lower leverage ratios, which mitigates but does not eliminate credit risk. Structural differences in deposit funding and capital buffers also mean banks are better positioned today to manage origination slowdowns.
February's stronger‑than‑expected mortgage approvals (56,700; Bank of England/Investing.com, Mar 30, 2026) point to resilient demand but warrant close monitoring of completions, early arrears and term‑structure risks before concluding a full recovery. Investors should prioritise originator selection, regional exposure and vintage quality over headline volumes.
Disclaimer: This article is for informational purposes only and does not constitute investment advice.
Sponsored
Open a demo account in 30 seconds. No deposit required.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.